{"id":194594,"date":"2021-09-20T13:48:38","date_gmt":"2021-09-20T13:48:38","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=79093"},"modified":"2021-09-20T13:48:38","modified_gmt":"2021-09-20T13:48:38","slug":"coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit","status":"publish","type":"post","link":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","title":{"rendered":"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit"},"content":{"rendered":"

DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. Dr. Nicolette will review progress in development of the company\u2019s allogeneic CAR-CIK technology platform for the treatment of liquid and solid tumors and will be available to participate in one-on-one meetings with investors during the conference being held September 21-23, 2021.<\/p>\n

The following link can be accessed on September 23, 2021 at 9:05 AM EDT to watch the presentation live:\u00a0https:\/\/wsw.com\/webcast\/oppenheimer16\/clmm\/2767483<\/a><\/p>\n

A webcast of the presentation will also be available on the News page of the CoImmune website at\u00a0https:\/\/www.coimmune.com\/news\/<\/a>.<\/p>\n

About CoImmune, Inc.<\/strong>
\nCoImmune is a privately held, clinical stage immuno-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a variation on CAR-T\u00a0therapy that promises enhanced efficacy with greatly reduced toxicity. Our autologous RNA-loaded dendritic cell technology for solid tumors\u00a0uses amplified total tumor mRNA to program highly engineered dendritic cells to generate immune responses against neoantigens without\u00a0the need to identify them. For more information visit\u00a0www.coimmune.com<\/u><\/a><\/p>\n

Investor Contact:<\/strong>
\nLori Harrelson
\nChief Financial Officer
\nCoImmune, Inc.
\nlharrelson@coimmune.com<\/a>
\n919-287-6349<\/p>\n

Media Contact:<\/strong>
\nAdam Daley
\nBerry & Company Public Relations
\nadaley@berrypr.com<\/a>
\n212-253-8881<\/p>\n","protected":false},"excerpt":{"rendered":"

DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) \u2014 CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virtual Oppenheimer Fall Healthcare Life Sciences & [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\nCoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Taiwan Newswire<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Taiwan Newswire\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) \u2014 CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virtual Oppenheimer Fall Healthcare Life Sciences & [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Taiwan Newswire\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-20T13:48:38+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/taiwannewswire.com\/#\/schema\/person\/90e83744b6bae95cc57e0b9b64e42ae1\"},\"headline\":\"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit\",\"datePublished\":\"2021-09-20T13:48:38+00:00\",\"dateModified\":\"2021-09-20T13:48:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\"},\"wordCount\":264,\"publisher\":{\"@id\":\"https:\/\/taiwannewswire.com\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\",\"url\":\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\",\"name\":\"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Taiwan Newswire\",\"isPartOf\":{\"@id\":\"https:\/\/taiwannewswire.com\/#website\"},\"datePublished\":\"2021-09-20T13:48:38+00:00\",\"dateModified\":\"2021-09-20T13:48:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/taiwannewswire.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/taiwannewswire.com\/#website\",\"url\":\"https:\/\/taiwannewswire.com\/\",\"name\":\"Taiwan Newswire\",\"description\":\"Discover the World through News.\",\"publisher\":{\"@id\":\"https:\/\/taiwannewswire.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/taiwannewswire.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/taiwannewswire.com\/#organization\",\"name\":\"Taiwan Newswire\",\"url\":\"https:\/\/taiwannewswire.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/taiwannewswire.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/taiwannewswire.com\/wp-content\/uploads\/2020\/06\/logo-taiwan.png\",\"contentUrl\":\"https:\/\/taiwannewswire.com\/wp-content\/uploads\/2020\/06\/logo-taiwan.png\",\"width\":216,\"height\":84,\"caption\":\"Taiwan Newswire\"},\"image\":{\"@id\":\"https:\/\/taiwannewswire.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/taiwannewswire.com\/#\/schema\/person\/90e83744b6bae95cc57e0b9b64e42ae1\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/taiwannewswire.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/taiwannewswire.com\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Taiwan Newswire","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","og_locale":"en_US","og_type":"article","og_title":"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Taiwan Newswire","og_description":"DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) \u2014 CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virtual Oppenheimer Fall Healthcare Life Sciences & [\u2026]","og_url":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","og_site_name":"Taiwan Newswire","article_published_time":"2021-09-20T13:48:38+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#article","isPartOf":{"@id":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/"},"author":{"name":"admin","@id":"https:\/\/taiwannewswire.com\/#\/schema\/person\/90e83744b6bae95cc57e0b9b64e42ae1"},"headline":"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit","datePublished":"2021-09-20T13:48:38+00:00","dateModified":"2021-09-20T13:48:38+00:00","mainEntityOfPage":{"@id":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/"},"wordCount":264,"publisher":{"@id":"https:\/\/taiwannewswire.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","url":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/","name":"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit - Taiwan Newswire","isPartOf":{"@id":"https:\/\/taiwannewswire.com\/#website"},"datePublished":"2021-09-20T13:48:38+00:00","dateModified":"2021-09-20T13:48:38+00:00","breadcrumb":{"@id":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/taiwannewswire.com\/coimmune-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/taiwannewswire.com\/"},{"@type":"ListItem","position":2,"name":"CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit"}]},{"@type":"WebSite","@id":"https:\/\/taiwannewswire.com\/#website","url":"https:\/\/taiwannewswire.com\/","name":"Taiwan Newswire","description":"Discover the World through News.","publisher":{"@id":"https:\/\/taiwannewswire.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/taiwannewswire.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/taiwannewswire.com\/#organization","name":"Taiwan Newswire","url":"https:\/\/taiwannewswire.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/taiwannewswire.com\/#\/schema\/logo\/image\/","url":"https:\/\/taiwannewswire.com\/wp-content\/uploads\/2020\/06\/logo-taiwan.png","contentUrl":"https:\/\/taiwannewswire.com\/wp-content\/uploads\/2020\/06\/logo-taiwan.png","width":216,"height":84,"caption":"Taiwan Newswire"},"image":{"@id":"https:\/\/taiwannewswire.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/taiwannewswire.com\/#\/schema\/person\/90e83744b6bae95cc57e0b9b64e42ae1","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/taiwannewswire.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/taiwannewswire.com\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/posts\/194594"}],"collection":[{"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/comments?post=194594"}],"version-history":[{"count":0,"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/posts\/194594\/revisions"}],"wp:attachment":[{"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/media?parent=194594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/categories?post=194594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/taiwannewswire.com\/wp-json\/wp\/v2\/tags?post=194594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}